List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 2588 studies with search of:   "Adenocarcinoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus
Conditions: Adenocarcinoma of Stomach;   Adenocarcinoma of GE Junction;   Adenocarcinoma of Esophagus
Interventions: Drug: Doxorubicin;   Drug: Cisplatin;   Drug: 5-fluorouracil
2 Recruiting Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia
Conditions: Unresectable Adenocarcinoma of the Esophagus;   Metastatic Adenocarcinoma of the Esophagus;   Unresectable Adenocarcinoma of Gastric Cardia;   Metastatic Adenocarcinoma of Gastric Cardia
Intervention: Drug: FOLFOX and Erlotinib
3 Recruiting Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
Conditions: Gastric Junction Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma
Intervention: Drug: Taxotere, Cisplatin, and 5-FU
4 Active, not recruiting Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature
Conditions: Pneumonic-Type Adenocarcinoma (P-ADC);   Lung Adenocarcinoma With Bronchiolo-Alveolar Feature
Intervention: Drug: Gefitinib
5 Recruiting Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
Conditions: Esophageal Adenocarcinoma;   Gastric Adenocarcinoma
Intervention: Drug: panitumumab, epirubicin, oxaliplatin, xeloda
6 Recruiting Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma
Conditions: Lung Cancer;   Adenocarcinoma
Intervention: Drug: sunitinib
7 Completed Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer
Conditions: Gastroesophageal Adenocarcinoma;   Gastric Adenocarcinoma
Intervention: Drug: OSI-7904L
8 Terminated Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
Conditions: Pancreatic Cancer;   Neoplasm Metastasis;   Adenocarcinoma
Interventions: Drug: talabostat mesylate tablets;   Drug: gemcitabine
9 Terminated VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features
Conditions: Carcinoma, Non-Small-Cell Lung;   Adenocarcinoma, Bronchiolo-Alveolar
Intervention: Drug: VELCADE
10 Recruiting The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy
Conditions: Adenocarcinoma;   Squamous Cell Carcinoma
Intervention: Radiation: CT, radiation therapy
11 Recruiting Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas
Conditions: Adenocarcinoma;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms
Intervention: Procedure: MiCK Assay
12 Active, not recruiting Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung
Conditions: Adenocarcinoma;   Non-Small Cell Lung Cancer
Intervention: Drug: Erlotinib
13 Suspended High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain
Conditions: Pain;   Pancreatic Adenocarcinoma;   Ductal Adenocarcinoma
Intervention: Procedure: High intensity focused ultrasound, HIFU
14 Terminated Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma
Condition: Gastric Adenocarcinoma
Intervention: Drug: Gleevec, Taxotere
15 Completed Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus
Condition: Adenocarcinoma
Intervention: Drug: Lapatinib (GW572016) oral tablets
16 Completed Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma
Condition: Pancreatic Adenocarcinoma
Interventions: Drug: oxaliplatin;   Drug: gemcitabine;   Drug: 5-FU/LV
17 Active, not recruiting Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma
Conditions: Colorectal Adenocarcinoma;   Liver Metastases
Intervention: Drug: perioperative chemotherapy
18 Completed EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas
Conditions: Adenocarcinoma;   Metastasis;   Pancreas Neoplasms
Interventions: Drug: Gemcitabine alone;   Drug: EndoTAG-1 and Gemcitabine;   Drug: EndoTAG-1 and Gemcitabine;   Drug: EndoTAG-1 and Gemcitabine
19 Recruiting Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) With Growth Factor Support in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Conditions: Gastroesophageal Junction Adenocarcinoma;   Gastric Cancer
Interventions: Drug: Docetaxel, Leucovorin, Fluorouracil, Cisplatin;   Drug: Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen
20 Recruiting Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma
Condition: Pancreatic Adenocarcinoma
Interventions: Drug: Modified CEA (CAP1-6D) Peptide (drug);   Drug: CEA Peptide;   Drug: Modified CEA (CAP1-6D) Peptide (drug)

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services